Ovarian cancer

Last Posted: Dec-02-2016 8AM

 Ovarian Cancer expanded expanded

PARP Inhibitors in Ovarian Cancer Treatment
DR Spriggs et al,NEJM, November 30, 2016

The Impact of an Expanded Genetic Testing Program and Selective Oophorectomy on the Incidence of Ovarian Cancer in West Pomerania.
Menkiszak J et al. Clinical genetics 2016 Sep

Finding all BRCA pathogenic mutation carriers: best practice models.
Hoogerbrugge Nicoline et al. European journal of human genetics : EJHG 2016 Sep S19-26

More information on this topic

Last Updated: Nov 30, 2016

• PARP Inhibitors in Ovarian Cancer Treatment
  DR Spriggs et al,NEJM, November 30, 2016
• Tracking the dissemination of a culturally targeted brochure to promote awareness of hereditary breast and ovarian cancer among Black women.
  Scherr Courtney Lynam et al. Patient education and counseling 2016 Oct
• http://www.mdedge.com/jcso/article/110048/gynecologic-cancer/hereditary-breast-and-ovarian-cancer-risk-assessment-minority
  Disease: Breast Cancer|Ovarian Cancer; Type: Data|Program; State: Georgia
• Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
  Disease: Ovarian Cancer|Breast Cancer; Type: Data|Program; State: Georgia
• Implementing Public Health Genomics in Your State: Resources from the CDC Office of Public Health Genomics
  Disease: Lynch syndrome|Breast Cancer|Ovarian Cancer; Type: Education; State: Multiple States
• Breast and Ovarian Cancer 
• Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
  Oberguggenberger Anne et al. Journal of psychosomatic research 2016 Oct 8939-45
• Hereditary breast and ovarian cancer: successful systematic implementation of a group approach to genetic counselling.
  Benusiglio Patrick R et al. Familial cancer 2016 Sep
• The Impact of an Expanded Genetic Testing Program and Selective Oophorectomy on the Incidence of Ovarian Cancer in West Pomerania.
  Menkiszak J et al. Clinical genetics 2016 Sep
• Finding all BRCA pathogenic mutation carriers: best practice models.
  Hoogerbrugge Nicoline et al. European journal of human genetics : EJHG 2016 Sep S19-26
• In honor of Ovarian Cancer Awareness Month
  G Hurst, Cure today, Sepetember 2016
• All women with ovarian cancer should be offered genetic testing – so why aren’t they? 
  E Smith, Science Blogs, August 17, 2016
• The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.
  Trivers Katrina F et al. Healthcare (Basel, Switzerland) 2015 3(4) 948-63
• Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
  Meisel Susanne F et al. BMC women's health 2016 16(1) 46
• JAX Genomic Education: Categorizing Cancer Risk
  Disease: Lynch syndrome|Ovarian Cancer|Breast Cancer; Type: Education; State: Multiple States

• CDC Information (10)
• CDC-Authored Pub (7)

• Human (59)
• Pathogen (0)

• Human (1528)
• Pathogen (0)

• Human (243)
• Pathogen (0)

• Guidelines (11)
• Tier Table (4)
• Synthesis (15)

• Huamn (107)
• Pathogen (0)

Relevant Resources

• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB